Tech & Pharma
Senhwa Biosciences has raised an additional US$17 million in Series B financing to drive its anticancer agents through critical clinical trials.
Echo Therapeutics, Inc. has granted Medical Technologies Innovation Asia, Ltd. rights to commercialize Echo’s Symphony CGM System in China.
Omron Healthcare will exclusively distribute NeuroMetrix’s point-of-care test for early detection of diabetic peripheral neuropathy in China.
ScinoPharm has completed construction of its Changshu plant on a 16-acre site in China.
A*STAR and KHIDI have signed a MOU to symbolize their growing bilateral cooperation in the field of biomedical sciences.
Strand Life Sciences is collaborating with El Camino Hospital to open a Strand Center for Genomics and Personalized Medicine in San Francisco, US.
IXICO plc and Beijing Union Medical have signed an MoU to jointly work on improving the diagnosis and treatment of dementia in China.
Takeda has announced clinical study results combining oral investigational MLN9708 with lenalidomide and dexamethasone, in patients with newly diagnosed multiple myeloma.
Teva and Takeda will jointly commercialize Teva’s glatiramer acetate formulation for the treatment of multiple sclerosis in Japan.
Helsinn Group, a Swiss pharmaceutical company that focuses on oncologic products, has opened a representative office in Beijing, China.